source
- Sanofi halts rare disease trial as Parabilis launches record biotech IPO amid European pricing debateSanofi announced it is stopping a Phase 3 trial of its experimental drug riliprubart in a rare autoimmune disease after an interim analysis showed the treatment did not work. The pause adds to rec…
- Republican pushback on methadone and buprenorphine raises concerns among addiction expertsRecent guidance from the Trump administration has revived a debate over the use of methadone and buprenorphine for opioid addiction treatment, prompting renewed scrutiny of federal policy. Addicti…